Cargando…
Issues related to the approval of the R21/Matrix-M malaria vaccine for use in Nigeria and Ghana
Autor principal: | Dzi, Kevin T. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582956/ https://www.ncbi.nlm.nih.gov/pubmed/37860804 http://dx.doi.org/10.3389/fpubh.2023.1237011 |
Ejemplares similares
-
Communicating Healthcare Economic and Pre-approval Information With Healthcare Decision-Makers: Opportunities Following the 21st Century Cures Act and FDA Guidance
por: Niyazov, Alexander, et al.
Publicado: (2018) -
Universal coverage and utilization of free long-lasting insecticidal nets for malaria prevention in Ghana: a cross-sectional study
por: Afagbedzi, Seth Kwaku, et al.
Publicado: (2023) -
The use of medications approved for alcohol use disorders in Italy
por: Fortinguerra, Filomena, et al.
Publicado: (2023) -
Evolution of anti-malaria policies and measures in P.R. China for achieving and sustaining malaria-free
por: Yin, Jian-Hai, et al.
Publicado: (2023) -
Changes of the Public Attitudes of China to Domestic COVID-19 Vaccination After the Vaccines Were Approved: A Semantic Network and Sentiment Analysis Based on Sina Weibo Texts
por: Gao, Hao, et al.
Publicado: (2021)